MedPath

The assessment efficacy of electrical brain stimulation among patients with drug-resistant epilepsy

Not Applicable
Conditions
drug resistant epilepsy.
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable
G40.21
Registration Number
IRCT20200111046082N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
22
Inclusion Criteria

age>=18 y/o
all of patients full filled ILAE criteria of drug-resistant epilepsy
participants were not good candidate for epilepsy surgery and or they will not surgery or they waited for epilepsy surgery.
obtaining signed consent

Exclusion Criteria

scalp diseases(such as eczema, skin lesions)
previous intracranial surgery, intracranial metal (out of mouth) such as cracking, surgical clip
implanted device such as cardiac pacemaker, VNS, Cochlear implantation
recurrent or severe headaches
previous head trauma and other related brain diseases
pregnancy and lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Investigating changes in the frequency of epileptic seizures. Timepoint: before intervention and monthly for 3 months. Method of measurement: seizure diary.;Investigating the frequency changes of interictal epileptiform discharges. Timepoint: immediately before and after intervention and then monthly for 3 months. Method of measurement: 30 minutes standard EEG.;Side effects. Timepoint: immediately after stimulation. Method of measurement: specialist visit.;Quality of life. Timepoint: before intervention and after 3 months. Method of measurement: full filling of the QoL in Epilepsy Inventory-89.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath